Literature DB >> 8452759

Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence.

P D Lyden1, J A Zivin.   

Abstract

Hemorrhagic infarction and cerebral hematoma are feared events that may follow cerebral ischemia. Newly developed thrombolytic agents may be effective stroke therapy, but may also promote hemorrhagic complications after ischemic stroke. It is therefore critically important to understand the true incidence of hemorrhagic transformation after ischemic stroke, and to identify if possible the mechanisms underlying the phenomenon. In recent years, studies using serial computed tomography to identify hemorrhage have shown that transformation occurs in 15 to 43% of patients presenting with ischemia. Experimental and clinical evidence support the notion that hemorrhage results from augmented collateral circulation into the ischemic zone, perhaps in concert with hypertension. Recanalization and distal migration of the thrombus are not factors that are associated with transformation. Pharmacologic recanalization using thrombolytic drugs are not likely to be associated with hemorrhage if reperfusion is accomplished very soon after the onset of neurologic symptoms.

Entities:  

Mesh:

Year:  1993        PMID: 8452759

Source DB:  PubMed          Journal:  Cerebrovasc Brain Metab Rev        ISSN: 1040-8827


  34 in total

1.  Validation of in vivo magnetic resonance imaging blood-brain barrier permeability measurements by comparison with gold standard histology.

Authors:  Angelika Hoffmann; Jörg Bredno; Michael F Wendland; Nikita Derugin; Jason Hom; Tibor Schuster; Hua Su; Peter T Ohara; William L Young; Max Wintermark
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

2.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

3.  Lys-plasminogen as an adjunct to local intra-arterial fibrinolysis for carotid territory stroke: laboratory and clinical findings.

Authors:  H J Freitag; V U Becker; A Thie; V Tilsner; A Philapitsch; H P Schwarz; U Webhof; A Müller; H Zeumer
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

Review 4.  Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications.

Authors:  Cumara B O'Carroll; Maria I Aguilar
Journal:  Neurohospitalist       Date:  2015-07

5.  Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging.

Authors:  Andrea Kassner; Timothy Roberts; Keri Taylor; Frank Silver; David Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

6.  Protective effect of melatonin upon neuropathology, striatal function, and memory ability after intracerebral hemorrhage in rats.

Authors:  Tim Lekic; Richard Hartman; Hugo Rojas; Anatol Manaenko; Wanqiu Chen; Robert Ayer; Jiping Tang; John H Zhang
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

7.  A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2015-02-01       Impact factor: 6.829

Review 8.  The High Cost of Stroke and Stroke Cytoprotection Research.

Authors:  Paul A Lapchak; John H Zhang
Journal:  Transl Stroke Res       Date:  2016-12-30       Impact factor: 6.829

9.  Short period of early reperfusion aggravates blood-brain barrier dysfunction during permanent focal ischemia in rats.

Authors:  Johannes Woitzik; Axel Hohenstein; Nils Hecht; Eric Juettler; Lothar Schilling
Journal:  Transl Stroke Res       Date:  2010-09-04       Impact factor: 6.829

10.  A novel approach to screening for new neuroprotective compounds for the treatment of stroke.

Authors:  Pamela Maher; Karmen F Salgado; Justin A Zivin; Paul A Lapchak
Journal:  Brain Res       Date:  2007-08-09       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.